COSCIENS Biopharma Other Current Liabilities

COSCIENS Biopharma (AEZS) currently reports a other current liabilities of $-900K as of June 2024. That compares with $160K in the prior-year period — down 672.2% year over year. Use the charts on this page to explore COSCIENS Biopharma's other current liabilities history and peer comparisons.

COSCIENS Biopharma's other current liabilities decreased from $160K to $-900K — a 672.2% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

COSCIENS Biopharma reported $-900K in other current liabilities as of June 2024. That compares with $160K in the prior-year period — down 672.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $-900K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for COSCIENS Biopharma, and consider following AEZS for alerts when major investors trade the stock.

COSCIENS Biopharma is classified in the Healthcare sector. On other current liabilities, it currently shows $-900K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AEZS with unrelated industries.